Showing results (31-40 of 39) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Cancers|December 23, 2022
Combination of STING and TLR 7/8 Agonists as Vaccine Adjuvants for Cancer ImmunotherapyShubhmita Bhatnagar, Vishnu Revuri, Manan Shah, et al.ACS Pharmacology & Translational Science|May 16, 2024
Insights into Mechanisms and Promising Triple Negative Breast Cancer Therapeutic Potential for a Water-Soluble Ruthenium CompoundNazia Nayeem, Sami Sauma, Afruja Ahad, et al.Materials Today. Bio|February 7, 2023
Incorporation of paclitaxel in mesenchymal stem cells using nanoengineering upregulates antioxidant response, CXCR4 expression and enhances tumor homingSwayam Prabha, Carmen Merali, Drishti Sehgal, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 6, 2025
A Novel Imidazoquinoline With TLR 7/8, STING, and Inflammasome Activity Demonstrates Antitumor Efficacy in Mouse Melanoma and Neu-Driven Mammary AdenocarcinomaShubhmita Bhatnagar, Vishnu Revuri, Carmen Merali, et al.Journal of Medicinal Chemistry|November 20, 2014
In vitro and in vivo evaluation of water-soluble iminophosphorane ruthenium(II) compounds. A potential chemotherapeutic agent for triple negative breast cancerMalgorzata Frik, Alberto Martínez, Benelita T Elie, et al.Apoptosis : an International Journal on Programmed Cell Death|April 3, 2015
Select microtubule inhibitors increase lysosome acidity and promote lysosomal disruption in acute myeloid leukemia (AML) cellsDannie Bernard, Marinella Gebbia, Swayam Prabha, et al.Blood|January 30, 2015
AML cells have low spare reserve capacity in their respiratory chain that renders them susceptible to oxidative metabolic stressShrivani Sriskanthadevan, Danny V Jeyaraju, Timothy E Chung, et al.Cancer Cell|June 10, 2015
Inhibition of the Mitochondrial Protease ClpP as a Therapeutic Strategy for Human Acute Myeloid LeukemiaAlicia Cole, Zezhou Wang, Etienne Coyaud, et al.The Journal of Clinical Investigation|December 4, 2012
Lysosomal disruption preferentially targets acute myeloid leukemia cells and progenitorsMahadeo A Sukhai, Swayam Prabha, Rose Hurren, et al.Pageof 4